The serotonin 2C receptor subtype (5-HT2C) seems to have various physiological roles in addition to the function of the receptor. The serotonin receptors are classified into many subtypes (1), especially more than 10 splicing variants have been reported for the 5-HT4 subtype (1, 2), which has been recently reported to be involved in the circadian clock (3, 4) . Among the various serotonin receptor subtypes, 5-HT2C is especially interesting. The history of studies on 5-HT2C can also convey its distinct personality. We are often surprised and puzzled by novel discoveries about 5-HT2C. In this review, the "curriculum vitae" of 5-HT2C is first introduced, followed by a discussion of the unique world of 5-HT2C, including RNA editing, short variants, relationship with small RNA, therapeutic potential for functional mental disease (FMD) such as depression and schizophrenia, and the "friendship" with Wakan-yaku (Sino-Japanese traditional medicine).
(1C) was the first gene cloned using this system (6) as well as a Na + channel and the substance P receptor. The genomic gene sequences contain unique characteristics. All of the gene sequences of the five types of 5-HT 1 receptors are intronless. By contrast, the 5-HT 2 receptor gene harbors introns. Sizes of 5-HT 2A and 5-HT 2B are approximately 60 kbp and 15 kbp, respectively. However, 5-HT2C has an abnormally long intron between the first and second exons, and the gene is large, approximately 183 kbp (7) .
Because 5-HT2C is encoded on the X chromosome (8) , it is possible that males are hetero-knockouts. Many reports show that 5-HT2C is involved in various FMD, such as schizophrenia, anxiety, and depression. With respect to the relationship to depression in particular, associations seem to fall between "epidemiological studies of depression in Japan" and the above-mentioned correlation of which "males seem to be the heteroknockout type" (discussed later).
With 5-HT2C functions and association with RNA editing and small RNA systems, exciting information continues to be provided. These interesting findings, which are still being actively studied, are described in specific chapters in this review.
RNA editing (Fig. 1)
There have been numerous reports regarding RNA editing over a long period. In mammals, after transcription from genomic DNA, adenosine residues on the RNA are deaminated by adenosine deaminase (ADAR) to inosine, which is recognized as guanine during translation (9) . Because RNA is energetically unstable, it is easy to modify. Therefore, it is thought that RNA editing functions as a rapid response to an environmental change. RNA editing usually occurs in a non-coding region and functions as a cis element, producing configurational changes in the RNA (10) . When RNA editing occurs in coding regions, the equivalent amino acid changes produce proteins with different functions. It has been also indicated that, in some cases, RNA editing itself is also necessary to produce proteins with normal functions. For example, the Q/R site of the glutamate receptor GluR2 is edited to prohibit Ca 2+ permeability (11) . In patients with amyotrophic lateral sclerosis (ALS), decreased editing at this Q/R site and SOD-1 sites induce abnormal increases in Ca 2+ permeability, resulting in nerve cell death (12) . In the case of hereditary skin pigment abnormality symptom (DSH), there is known to be an abnormality in editing at 32 sites in the ADAR type 1 enzyme (13, 14) .
A review of 5-HT2C mRNA editing was previously published in this journal (15) . After publishing the pre-vious review, the functional significance of editing and its association with various phenomena has become increasingly clear. To date, 5-HT2C is the only example of a G protein-coupled receptor (GPCR) that is edited in a coding region. In the region where 5-HT2C is edited, there are five extremely limited positions that encode the second intracellular loop domain. A relationship between 5-HT2C and depression (16, 17) and other FMD such as schizophrenia (18, 19) has been demonstrated. However, details of the association between 5-HT2C editing and FMD are still being investigated. In the case of neurodegenerative diseases (NDD) (20) such as Alzheimer's disease and Parkinson's disease, the structural changes in tissues are clear, and the target molecules involved in NDD have been identified. It may be important to find the visible clear changes like those for therapy of illness and drug development. In FMD, a clear "digitalic" change on the 5-HT2C RNA sequence, from adenosine to inosine by editing, may provide the opportunity. Actually, efforts to find drugs effective for FMD are supported by information about editing "digital" mechanisms (21) .
The 5-HT2C is coupled to PL-C and reportedly, PL-A2 and PL-D (1). Because the editing sites are also important for G protein-coupling, the physiology has mainly been studied with respect to editing and the association with PL-C activity. Five editing sites participate in the coding of three amino acid residues. The non-editing type is assumed to be an INI type, producing an amino acid sequence of AIRNPIE in the applicable region. The fully edited type, termed the VGV type, produces an amino acid sequence of AVRGPVE. In addition, the editing VSV type is amenable for experiments because the editing rate at the E site is normally very low. There are many papers that report the functional differences between INI and VGV/VSV. In NIH-3T3 cells expressing each type, concentrationdependent curves of inositol phosphate generation (22) and intracellular Ca 2+ concentrations (23) are shifted to the right by editing, suggesting that editing attenuates the agonistic response of the receptor. The coupling efficiency of the receptor to G protein is suggested to participate in this effect (21) . A transgenic mouse expressing the VGV type has been reported (24) . Experimental results using VGV transgenic mice seem to contradict the above-mentioned molecular analyses; the interpretation of this point will be discussed in the "short variant" section.
The density of 5-HT2C increases in VGV transgenic mice compared with wild-type mice (25) . Although it is expected that responsiveness attenuates in the VGV type from the above-mentioned molecular knowledge, the 5-HT2C-related responses for the agonist actually increase in the VGV animal model. Increased anxiety (26, 27) and decreased fat (24) are observed. Because food intake is higher in the VGV type, this change is thought to be caused by energy increases due to hyperfunction in the sympathetic system. It has also been suggested that decreased short variant generation, which is described later, is also related to the increase in 5-HT2C density (27) . In the case of 5-HT2C-knockout mice, the mice become bulimic and obese (28) .
There are many reports comparing the biological response between the non-editing type (INI) and full editing type (VGV/VSV), but in fact, the editing rate in each region varies. The transmission efficiency of the 5-HT2C signal which is prescribed under each situation of the cell may be possibly assumed by editing. Among 5 editing sites, the editing frequencies at the A and B sites are kept low in the rat brain during fetal development, but these are approximately completely edited from just after birth (29) . Under full editing of the A/B site, namely, in the brain after birth, it is suggested that editing of the C site decides the strength of the 5-HT2C signal (30) .
Much knowledge exists regarding the influence of various antidepressants on 5-HT2C editing. However, due to differences in drugs and brain area, reports vary widely. A review written by Martin et al. (16) goes into great detail about the point, especially on page 213. However, there is no unified opinion on the relationship between editing and antidepressant effects, which remains a matter of debate. Symptoms of depression are well-known side effects of cytokine treatment for hepatitis, and one of the treatment drugs, interferon-a, induces rapid 5-HT2C editing (31) .
The editing rate at each editing site in the 5-HT2C mRNA differs among mouse strains (32) . The tertiary structure of the 5-HT2C mRNA and the loop sequence regions also vary widely among humans, rats, and mice (33, 34) , although the editing area exists in a loop in all species. These observations may indicate that 5-HT2C mRNA editing can adapt to environmental changes depending on the energetic instability of the RNA. It can be expected that the 5-HT2C mRNA works not only as the template of the receptor proteins but also has many dynamic functions to rapidly respond to environmental necessities. Interest in 5-HT2C also extends to RNA studies.
Short variant (Fig. 2)
It has long been reported that the 5-HT2C mRNA has a short variant in which a 95 nt sequence is deleted compared with the full-length receptor type (35, 36) . This deletion occurs in an exon, not between an exon and an intron. All editing sites are included in the deleted region. Moreover, as a result of the deletion, a novel termination codon is generated, resulting in a shortened protein that does not achieve the full function of the receptor. The existence of the shortened protein was demonstrated by making an antibody against its predicted amino acid sequence (35) . Although the existence of the short variant has long been known, its physiological significance remained unidentified. Only a few reports mentioned the expression difference by neuronal differentiation in cloned neuronal cells (37) and the expression changes during the cultivation period in primary cultured neuronal cells (38) . Recently, this short variant protein was shown to combine with the full-length 5-HT2C protein to form a hetero-dimer (27) . In other words, the idea that the short variant controls the function of the 5-HT2C is emerging. Possible reasons why the 5-HT2C response is rather strong in the fully edited-type transgenic mice are as follows: the editing system can not contribute to function in transgenic mice; the short variant, which inhibits 5-HT2C function by forming a heterodimer, is not produced; and then the quantity of the free 5-HT2C protein is increased in fully edited-type transgenic mice (27) .
Association with the small RNA system (Fig. 3) SnoRNA MBII-52, a type of small RNA, has been shown to participate in 5-HT2C editing (39) and generation of the short variant (40, 41) . A highly homologous sequence to the 5-HT2C editing site is present in MBII-52. MBII-52 combines with the 5-HT2C mRNA in that region and promotes receptor-type splicing. In Prader-Willi syndrome (PWS), which results in obesity, short stature, poor muscle tone and other symptoms, the genomic DNA domain encoding the MBII-52 (15q11-13 in human) is lacking (42) ; therefore, the editing and expression of 5-HT2C receptor-type mRNAs are influenced (25) . Because the 5-HT2C knockout mouse becomes obese, the participation of these will be deter-mined. It has been also reported that MBII-52 regulates 5-HT2C RNA editing in cultured cells, resulting in an increase in the receptor type.
In this way, the expression of 5-HT2C mRNA is controlled in a complex manner by editing, a short variant and a small RNA.
Association with functional mental diseases (FMD)
Much has been reported regarding the relationship between 5-HT2C and FMD, schizophrenia, anxiety, and depression. Excellent reviews exist (16, 18, 20, 43) . Especially about depression, the antagonistic effects of antidepressants on 5-HT2C have already been shown in 1989 (44) . There are also many reports of effects such as expression changes (45, 46) . However, a clear and unified conclusion has not been provided until now, which may be why ambiguity remains in the FMD world, in addition to the complexity of the 5-HT2C system as mentioned above. In the case of an NDD such as Alzheimer's disease and Parkinson's disease, organic/ structural denaturation is clear and easy to detect, and these diseases are progressive and irreversible. A mechanism to standardize NDD may be "protein polymerization" and/or a "b-sheet like structure" such as amyloid b, a-synuclein, and prion (20) . Target for studies are going to be clarified by previous research on NDD. However, for FMD, it is difficult to detect changes in the tissue, and a functional change is important. The disease condition of a patient is not stable and is sometimes bipolar/ multipolar. In other words, FMD is a disease that can be completely reversed. In a recent imaging study using functional MRI and other techniques, functional changes such as those that occur in depression can be detected as an objective signal (47 -50) . PET probes for 5-HT2C are also useful for understanding distribution and modulation (51) . Accordingly, it would be better to understand that the depressive brain is in an excited rather than suppressed state. In schizophrenia, MRI also clarifies the minute structural changes in limited areas of the patient's brain (52) . The development of imaging methods will supply methods for understanding the functional changes in FMD. Using the valuable methods of imaging to study the relationship between the complex 5-HT2C system and FMD, the association will become clear and increase the value of 5-HT2C as a superhero.
As described above, because 5-HT2C is encoded on the X chromosome, men may be a natural heteroknockout of 5-HT2C. It is also known that paternal heredity participates in PWS, to which HBII-52 is related. There is epidemiological evidence regarding the gender gap in suicide and depression. In Japan, epidemiological studies show that the number of female patients with depression is more than double that of men (Table 1) . However, the number of suicides among men is more than double that of women. One hypothesis is that 5-HT2C is involved in the generation of depression by being affected and leads to suicide when the effect becomes homogeneous. Because men are the heteroknockout type, the affecting influence may more easily cause suicide. In addition, the number of depression/ suicides among men depends on the generation, whereas for women, it is approximately constant across generations. These observations indicate that depression in women is highly hereditable, whereas in men, it is epigenetically influenced. An association between 5-HT2C editing and suicide has been suggested (53) . The 5-HT2C RNA is strongly controlled by epigenetic regulation as mentioned above. The relationship between 5-HT2C and depression are of increasing interest as well as gender difference, also reportedly in 5-HT1A (54) .
Friendship with Wakan-yaku (Sino-Japanese traditional medicine)
Kanpo Medicine, which uses Wakan-yaku as treatment drugs, is the medical system practiced in Japan which was based on the Chinese classical traditional medicine. The concept of "the mind" is very important in Kanpo and Wakan-yaku, and many prescriptions that act on mood disorders exist. 5-HT2C is also reportedly involved in the Wakan-yaku effects. Rikkunshito is a Wakan-yaku prescription consisting of eight kinds of crude drugs. It has been reported that Rikkunshito increases the release of the appetite-increasing peptide ghrelin in plasma and the brain, and 5-HT2C block by Rikkunshito in the hypothalamus participates in the increase of the ghrelin release (54) . It is also shown that long term treatment with Hochuekkito, another Wakan-yaku prescription with similar composition of crude drugs of Rikkunshito, increases 5-HT2C mRNA (55) and other gene expressions (56) in the brain and cultured cells. The number of the suicides is based on statistics from the National Police Agency from 2013, and the number of the suicides is based on statistics from the Ministry of Health, Labor and Welfare from 2011 in Japan. The ratio indicates the number of suicides divided by the number of patients with depression.
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Conclusion (Fig. 4) All of the actions of 5-HT2C have not been listed here. An association between 5-HT2C and insulin release has also been reported (59) . Much of what is known about 5-HT2C cannot be listed due to space limitations and additional information the author is not currently aware of may also exist. It is a fact, at least, that 5-HT2C mRNA is regulated by editing, a short variant and a small RNA. However, further studies are needed to fully establish the "functional significances of the facts". With respect to the 5-HT2C mRNA, studies till now are underway to clarify the mechanism and its significance as precursors of the "receptor proteins". During the past decade, it was revealed that RNA itself has enzymatic functions as ribozymes by adopting a three-dimensional tertiary structure (60, 61) . Species differences in the two-dimensional structure of the 5-HT2C mRNA exist (33, 34) . The tertiary structure of the 5-HT2C mRNA is more likely to be controlled by various phenomena. In addition, it was recently shown that miRNAs are generated from the non-coding region of the 5-HT2C mRNA (62) . Through a novel mechanism independent of receptor function, the "5-HT2C mRNA" may be involved in the "RNA universe". The observations on 5-HT2C mRNA suggest that it may participate in novel transduction mechanisms. Recently, it has been reported that transgenic mice of IVI expression (non-edited type) show reduced depressive-like and fear-associated behavior without an effect on anxiety. The knock-in mice also show increased 5-HT 1A mRNA expression but not an increase in 5-HT 2A (63) .
Pharmacological studies on 5-HT2C have so-far been based on the actions of this receptor. If the novel physiological significance of the 5-HT2C RNA becomes clear, novel pharmacological approaches to studying it will be developed. Pharmacological investigations are no doubt required to clarify the molecular mechanisms of the novel physiological functions of 5-HT2C in RNA universe. For example, though the enzyme adenosine deaminase participates in the editing of mRNA and the inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine was found to suppress the 5-HT2CR mRNA editing in primary cultured cortical cells (64) . In any case, the pharmacological approach as the next step will become important. New and interesting "questions" will be provided by further studies on 5-HT2C mRNA. Fig. 4 . Regulation of 5-HT RNA in the RNA universe. The 5-HT2C RNA is highly regulated in the "RNA universe" by editing, generation of a short variant, small RNAs, and other unknown mechanisms. To date, there have been several reports that the regulated RNA is translated into various types of receptor proteins with different activities for receptors. 1) RNA editing occurring in five neighboring sites generates receptor type proteins with various activities on inositolphosphates formation. 2) RNA editing stimulates formation of short variant protein. 3) Short variant protein forms a dimer with receptor type protein, resulting in the control of the receptor activities. 4) HBII-52, a kind of small RNA, stimulates expression of the receptor type of RNA and inhibits the editing. 5) In addition, since changes of editing in the neuronal development stage has been reported, the 5-HT2C RNA products in itself in the RNA universe will have physiological actions directly, which is of interest for future studies.
